Literature DB >> 2873746

Glutamine and glutamate kinetics in humans.

D Darmaun, D E Matthews, D M Bier.   

Abstract

To study glutamate and glutamine kinetics, 4-h unprimed intravenous infusions of L-[15N]glutamate, L-[2-15N]glutamine, and L-[5-15N]-glutamine were administered to healthy young adult male subjects in the postabsorptive state. Arterialized-venous blood samples were drawn and analyzed for glutamate and glutamine 15N enrichments. The fractional turnover rates of the tracer-miscible glutamate and glutamine pools were fast, 8.0 and 2.8% min-1, respectively. The glutamate tracer-miscible pool accounted for less than one-tenth the estimated free glutamate pool in the body. The plasma glutamate amino N, glutamine amino N and glutamine amide N rates of appearance were 83 +/- 22 (means +/- SD), 348 +/- 33, and 283 +/- 31 mumol X kg-1 X h-1, respectively. The glutamine amide N appearance rate was 20% slower than the amino N appearance rate, indicating that glutamine transaminase is an active pathway in human glutamine metabolism. From measurement of transfer of tracer 15N, we found that only 5% of the glutamine synthesized in cells and released into plasma was derived from intracellular glutamate that had mixed with plasma. These data demonstrate that intravenously administered tracers of glutamate or glutamine do not mix thoroughly with the intracellular pools, and their measured kinetics reflect transport rates through plasma rather than whole-body fluxes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2873746     DOI: 10.1152/ajpendo.1986.251.1.E117

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  34 in total

1.  An evaluation of erythrocytes as plasma glutamate scavengers for enhanced brain-to-blood glutamate efflux.

Authors:  Yin Wang; Miroslav Gottlieb; Vivian I Teichberg
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

2.  Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model.

Authors:  Laura M Shelton; Leanne C Huysentruyt; Thomas N Seyfried
Journal:  Int J Cancer       Date:  2010-11-15       Impact factor: 7.396

3.  Conformational changes in the activation loop of mitochondrial glutaminase C: A direct fluorescence readout that distinguishes the binding of allosteric inhibitors from activators.

Authors:  Clint A Stalnecker; Jon W Erickson; Richard A Cerione
Journal:  J Biol Chem       Date:  2017-02-14       Impact factor: 5.157

4.  Whole body and skeletal muscle glutamine metabolism in healthy subjects.

Authors:  B Mittendorfer; E Volpi; R R Wolfe
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-02       Impact factor: 4.310

5.  Does oral glutamine improve insulin sensitivity in adolescents with type 1 diabetes?

Authors:  Lournaris Torres-Santiago; Nelly Mauras; Jobayer Hossain; Arthur L Weltman; Dominique Darmaun
Journal:  Nutrition       Date:  2016-09-20       Impact factor: 4.008

6.  Total parenteral nutrition with glutamine dipeptide after major abdominal surgery: a randomized, double-blind, controlled study.

Authors:  B J Morlion; P Stehle; P Wachtler; H P Siedhoff; M Köller; W König; P Fürst; C Puchstein
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

7.  Plasma Glutamine Is a Minor Precursor for the Synthesis of Citrulline: A Multispecies Study.

Authors:  Juan C Marini; Umang Agarwal; Inka C Didelija; Mahshid Azamian; Barbara Stoll; Sandesh Cs Nagamani
Journal:  J Nutr       Date:  2017-03-08       Impact factor: 4.798

8.  Physical inactivity decreases whole body glutamine turnover independently from changes in proteolysis.

Authors:  Francesco Agostini; Martina Heer; Gianfranco Guarnieri; Gianni Biolo
Journal:  J Physiol       Date:  2008-07-31       Impact factor: 5.182

9.  Alterations in glutamine metabolism and its conversion to citrulline in sepsis.

Authors:  Christina Kao; Jean Hsu; Venkata Bandi; Farook Jahoor
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-04-23       Impact factor: 4.310

Review 10.  α-Ketoglutaramate: an overlooked metabolite of glutamine and a biomarker for hepatic encephalopathy and inborn errors of the urea cycle.

Authors:  Arthur J L Cooper; Tomiko Kuhara
Journal:  Metab Brain Dis       Date:  2013-11-14       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.